CKS1BP3

Across TCGA pan-cancer cohorts, CKS1BP3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated CKS1BP3 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher CKS1BP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CKS1BP3 expression acts as an unfavorable survival marker, although some lineages such as COAD and OV show a favorable association.

UVM, LIHC, and KICH are the cancer types where CKS1BP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.476	0.776	.004	45	view →
LIHC	OS	Tertile	II,III,IV	0.337	0.717	<.001	44	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	36	view →
COAD	OS	Median	III,IV	0.823	0.545	.001	35	view →
UCEC	DFS	Median	All	0.776	0.867	.002	22	view →
ACC	DFS	Quartile	All	0.176	0.700	.011	17	view →
OV	OS	Tertile	IV	0.838	0.581	.006	16	view →
THCA	OS	Tertile	All	0.992	0.918	.019	13	view →
KIRC	DFS	Median	IV	0.228	0.399	.013	12	view →
LUAD	DFS	Tertile	IV	0.876	0.220	.014	12	view →
SKCM	OS	Median	IV	0.316	0.768	.017	6	view →
MESO	DFS	Quartile	II,III,IV	0.485	0.325	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

CKS1BP3–UVM (DFS)

Open the UVM breakdown →